Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002
In the Special Article by Lloyd et al titled "Accuracy and Ambiguity in Counseling Patients About Genetic Risk," published in the November 12, 2001, issue of the ARCHIVES (2001;161:2411-2413), the color did not appear in Figure 1. Figure 1 is reprinted correctly here.
Sensitivities, specificities, and positive and negative predictive values of genetic testing in 2 groups of patients with hemochromatosis. A, Patients with elevated transferrin iron saturation only. B, Patients with diabetes mellitus and elevated transferrin iron saturation. Blue and red marks indicate true positives; blue marks alone, false negatives; red marks alone, false positives; and no marks, true negatives. The pretest probability for patients with and without diabetes mellitus and elevated transferrin iron saturation is assumed to be 5% and less than 1%, respectively.
Error in Figure. Arch Intern Med. 2002;162(1):32. doi:10.1001/archinte.162.1.32